The effects of modulating tetrahydrobiopterin (BH4) levels with a metabolic precursor, sepiapterin (SP), on dextran sodium sulfate (DSS) induced colitis and azoxymethane (AOM) induced colorectal cancer were studied. SP in the drinking water blocks DSS-induced colitis measured as decreased disease activity index (DAI), morphological criteria and recovery of Ca for alleviating some forms of colitis and potentially minimizing the potential for colorectal cancer in patients with colitis.
Introduction
The link between inflammation and cancer was proposed 150 years ago when Virchow argued that cancers arise at sites of chronic inflammation (Balkwill and Mantovani, 2001 ). The underlying mechanisms involve the recruitment of inflammatory cells and the generation of cytokines and enzymes that facilitate the development of the inflammatory microenvironment of the tumor and which are associated with other inflammatory diseases such as colitis. Important roles reactive oxygen/nitrogen species (ROS/RNS), in tumor initiation and progression are also clearly established (Wink et al., 1998; Westbrook and Schiestl, 2010) .
Expression of inducible NOS (NOS-2) in both epithelial and invading inflammatory cells
is enhanced in colitis contributing to nitro-oxidative stress throughout carcinogenesis and providing one explanation for the enhanced protein Tyr nitration observed in these CRC tissues (Itzkowitz and Yio, 2004) . Of potential significance to colitis is the nitration and inhibition of the Ca v 1.2 calcium channel of colonic smooth muscle and its role in motility changes resulting from colitis (Ross et al., 2007; Kang et al., 2010) . However, equally elevated levels of protein nitration are observed in chemically induced colitis of wild type and NOS-2 knockout mice and no difference in CRC incidence is observed in comparing these mice (Seril et al., 2007) . One explanation is a compensatory mechanism involving increased expression of other NOS isoforms, e.g. the endothelial NOS (NOS-3).
For all NOS isoforms, a transfer of electrons is coupled with the oxidation of arginine by a mechanism in which the cofactor tetrahydrobiopterin (BH4) donates electrons to the NOS JPET #203828 5 ferrous dioxygen complex to initiate oxidation. The concentration ratio of BH4 to its oxidation product 7,8-dihydrobiopterin (BH2) is critical since BH2 binds with equal affinity for NOS but in a catalytically non-productive manner. When the BH4:BH2 ratio is much greater than one, NOS catalysis generates NO and citrulline and NOS is said to be "coupled". The primary target of NO is soluble guanylate cyclase (sGC), stimulate of cGMP synthesis, and activation of protein kinase G (PKG). This pathway is important in smooth muscle relaxation and synaptic transmission. In the vasculature, the NO-sGC-PKG pathway is anti-inflammatory. In colon carcinoma cell lines, increased PKG expression reduces cell proliferation and enhances apoptosis (Deguchi et al., 2005; Cen et al., 2008; Kwon et al., 2010) .
When the BH4:BH2 ratio is low, as in chronic inflammatory conditions, coupling is less efficient and superoxide (O 2 -) is produced rather than NO. Under these conditions NOS is "uncoupled" and has been called "peroxynitrite synthase (Stuehr et al., 2001; Mikkelsen and Wardman, 2003; Alp and Channon, 2004; Cai et al., 2005) . Peroxynitrite is a Tyr nitrating free radical. NOS ucoupling is extensively investigated in vascular diseases and a synthetic BH4 (Kuvan) is currently in clinical trials for these diseases and approved for use in the treatment of some forms of phenylketouria (Forstermann, 2010; Schmidt et al., 2010) .
A previous study demonstrated that dietary supplementation with nitrite ameliorated DSS-induced colitis possibly by bypassing NOS activity and utilizing an alternative mechanism of NO generation involving the reduction of nitrite (Lundberg and Weitzberg, 2009; Ohtake et al., 2010) . The goal of the present study is to examine the effect of modulating BH4 levels by This article has not been copyedited and formatted. The final version may differ from this version. s  e  l  e  c  t  e  d  o  n  t  h  e  b  a  s  i  s  o  f  p  r  e  l  i  m  i  n  a  r  y  e  x  p  e  r  i  m  e  n  t  s  d  e  m  o  n  s  t  r  a  t  i  n  g  t  h  a  t  t  h  i  s  d  o  s  e  i  n  c  r  e  a  s  e  d   B  H  4  :  B  H  2  l  e  v  e  l  s  i  n  a  n  d  w  a  s  c  y  t  o  t  o  x  i  c  t  o  d  i  f  f  e  r  e  n  t  t  u  m  o  r  c  e  l  l  l  i  n  e  s  g  r  o  w  n  a  s  x  e  n  o  g  r  a  f  t  s  o  r  i  n   t  i  s  s  u  e  c  u  l  t  u  r  e  (  R  a  b  e  n  d  e  r  a  n  d  M  i  k  k  e  l  s  e  n  ,  i  n  p  r  e  p  a  r  a  t  i  o  n  ) .
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(10mg/kg) seven days prior to the onset of DSS treatments; three week long courses of DSS were given as above separated by 2 weeks of DSS-free water. Animals were sacrificed 3 weeks after the final DSS treatment, 77 days after AOM treatment. Mice designated for SP treatment received 4mg/100ml SP in their drinking water continually starting 3 days before DSS treatment.
To inhibit sGC, animals were injected ip daily with 20 mg/kg ODQ as described in (Tseng et al., 2011 ).
All animals were monitored daily for weight, stool consistency and the presence of blood in the excreta. All procedures were approved by the Institutional Animal Care and Use
Committee of Virginia Commonwealth University and conformed to the guidelines established by the National Institutes of Health, protocol numbers AM10080 and AM10185.
BH4/BH2 analysis:
The purification and analysis of colonic biopterins was a modification of a previously described method (Fukushima and Nixon, 1980; Sawabe et al., 2004) . Partisphere RTF C18 4.6x250mm (Whatman, Clifton, NJ) and the mobile phase was 7% methanol. BH4 and BH2 were quantified as described elsewhere (Sawabe et al., 2004 
Immunohistopathology
Colons were excised from animals, flushed with PBS, cut longitudinally, rolled into "Swiss rolls" and immediately flash frozen in liquid N 2 . Frozen Swiss rolls were embedded in Tissue-Tek OCT freezing medium and cryosections prepared.
For macrophage detection, frozen sections were fixed in ice-cold acetone for 10 min.
After donkey serum blocking for 60 min at RT, the sections were stained with primary mAb for 
Statistics:
For contraction measurements the data from different groups were analyzed by two way-ANOVA followed by Bonferroni's post-test. P as the only effect. The difference of least square means for each group was tested using a F test for statistical significance.
Results

SP treatment ameliorates DSS-induced colitis.
To determine the effect of SP upon experimental colitis animals were placed in four groups drinking water doped with DSS, SP, DSS and SP or untreated water and were monitored for the development of colitis. Colitis was measured by daily recordings of weight, stool consistency, and the presence of blood in the excreta. As shown in Figure 1A , by day 7 animals receiving DSS have lost 14% of their starting body weight. The weight loss in DSS treated animals is prevented by the addition of SP to the drinking water. Similarly, the disease activity index ( Figure 1B ) is significantly increased in only the DSS treated animals at day 7.
The development of DSS-induced colitis and its partial mitigation by co-treatment with SP was also monitored by H&E staining of frozen sections of colons from treated animals. As shown in Figure 2 , a loss of villi and crypts is observed in the DSS alone treated colon and cotreatment with SP mostly mitigates this change in colonic morphology. Separation of the muscle and muscularis mucosae is predominantly observed in both the DSS-treated colons but was also observed to some degree in SP colons indicating mild colitis in DSS with SP colons that is not detected by assessment of the disease activity index.
This article has not been copyedited and formatted. The final version may differ from this version. Figure 1B ). These results confirm that DSS treatment elicits an inflammatory response and that it is at least partially reversible with SP.
To determine how SP treatment reduced macrophage recruitment in DSS-treated colons, gene expression analysis was performed to determine the expression of pro-and antiinflammatory cytokines. As shown in Figure 5 , DSS treatment elicited significant increases in the expression of mRNA for the pro-inflammatory cytokines IL-1β, IL-6 and IL-17A. This increased cytokine expression is blocked by the addition of SP to the drinking water. We also assayed for the anti-inflammatory cytokine IL-37 since this cytokine has been shown to protect the mouse colon from DSS induced colitis (McNamee et al., 2011) . However, IL-37 expression was not detected in any of the colon samples tested. The observed changes in cytokine expression indicate that SP acts by disrupting both the acute phase response and delayed-type immune reaction.
SP blocks the DSS induced reduction in colon cGMP levels.
To determine if DSS induced inflammation decreases NOS coupling and thus NO production we assayed the BH4:BH2 ratio following 7 days DSS treatment. Colonic cGMP levels were also measured at this time as an indirect measure of coupled NOS activity. While we were unable to observe any significant change in the BH4/BH2 ratio with DSS treatment, production of cGMP -an indirect measure of NO production -was significantly reduced in DSS treated colons ( Figure 7B , P<0.01). The DSS-induced reduction in levels of cGMP was reversed by SP treatment. SP alone significantly increased cGMP production relative to control animals.
cGMP is also generated by a NO-independent but Ca 2+ -requiring membrane bound guanylate cyclase. That SP treatment reverses the effect of DSS on colon cGMP levels suggests that increased NO generation is required. To further test this mechanism we used the sGC inhibitor, ODQ, which is an irreversible inhibitor of sGC. In these experiments, ODQ was delivered ip on a daily basis with changes in the SP-containing water. As shown in Figure 7B , ODQ blocked the activity of SP to prevent the decrease in cellular cGMP in the colons of mice treated with DSS. Parallel experiments were performed in which the DAI of the animals were measured. As shown in Figure 7A , ODQ also prevented the SP-induced recovery in the DAI of DSS treated animals.
SP inhibits DSS-induced protein Tyr nitration.
Previous investigators have termed uncoupled NOS as a "peroxynitrite synthase". Thus 
SP partially protects against AOM/DSS induced adenocarcinoma.
Given that SP protects against the development of DSS-induced colitis we tested the hypothesis that this protection may extend to preventing the development of AOM/DSS induced CRC. Animals received a dose of AOM followed by three one-week courses of DSS with or without SP co-treatment. Following 70-days of treatment, colons were excised and assayed morphologically for tumor development. Individual single treatments with AOM or DSS did not induce cancer formation as previously described (Neufert et al., 2007) . As seen in Figure 9A , the combined AOM+DSS treatment induced tumor formation that was significantly reduced by cotreatment with SP (P<0.05). In the ten animals treated with AOM+DSS as described, the contribute to the development and prevention of colitis. One mechanism that deserves consideration also involves sGC and its role in inhibiting the recruitment of inflammatory cells to sites of tissue injury (Ahluwalia et al., 2004) . In endothelial cells sGC activity inhibits inflammatory cell recruitment by blocking P-selection expression (Ahluwalia et al., 2004) . Thus besides restoring maintaining barrier function and the normal balance of secretion and absorption, SP by protecting sGC from oxidative inactivation may also mitigate the effects of DSS-induced colitis by preventing the recruitment of inflammatory cells.
The three cytokines examined, IL-1β, IL-6, and IL-17 have all been associated with DSS induced colitis and with colon CRC (Kaler et al., 2009; Hyun et al., 2010; Waldner et al., 2012) . One unifying feature for all three cytokines is their transcriptional regulation by NF-κB (Funakoshi et al., 2012) . A relatively specific inhibitor of NF-κB, dehydroxymethylepoxyquinomicin, inhibits the mRNA expression of IL-β, IL-6, TNF-α, IL12p40, IL-17A and MCP-1 and also suppresses both DSS and TNBS-induced colitis. With respect to how SP inhibits pro-inflammatory cytokine expression one mechanism is based on a previous study showing that low inflammatory levels of RNS result in the nitration Tyr181 of IκBα, the inhibitor protein of NF-κB, dissociating the complex and facilitating translocation of active transcription factor, p65/p50, into the nucleus (Yakovlev et al., 2007) . SP treatment by increasing the BH4:BH2 recouples NOS activity enhancing NO generation and reducing RNS generation necessary for Tyr nitration. Furthermore, NO dependent S-nitrosylation of p65 also inhibits NF-κB transcriptional activity (Marshall et al., 2004) . Thus recoupling of NOS potentially inhibits NF-κB activity leading to suppression of the inflammatory response critical for colitis and colitis associated carcinogenesis (Sawabe et al., 2004; Atreya et al., 2008; Shaked et al., 2012) . Regardless of the mechanism of SP activity these results suggest a potential approach in mitigating colitis and associated CRC by modulating colonic BH4/cGMP metabolism. One potential candidate is a synthetic BH4, Kuvan, currently used for treatment of some types of phenylketonuria. Kuvan is also being examined in Phase 2 trials for treatment of different inflammatory and vascular diseases (Burton et al., 2011; Cunningham et al., 2012) .
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